Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5574218 | Journal of Stroke and Cerebrovascular Diseases | 2017 | 6 Pages |
Abstract
With the growth of obesity in the United States and the lack of data supporting dose capping of alteplase, it remains unclear if this dosing practice should continue to be accepted without question. Further studies are needed to assess optimum dosing practices particularly given the obesity epidemic.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Jeffrey PharmD, Jay MS, Hannah MSN, Michael PhD, Matthew MD, MS,